“Hypertriglyceridemia: From Biochemical Aberration to Cardiometabolic Syndrome - Emerging Pathophysiology, Clinical Challenges, and Novel Therapeutics ”. Diabzen, vol. 3, no. 2, Nov. 2025, pp. 11-15, https://www.thediabzen.com/index.php/d/article/view/12.